Cargando…

Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19

OBJECTIVES: Risk of hospital-acquired COVID-19 (HA-COVID-19) infection is increased by cohorting infected and non-infected patients together in assessment areas, whist awaiting laboratory PCR results. Molecular point-of-care tests (mPOCT) reduce time to results and improve patient flow but the impac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Livingstone, Robert, Lin, Hlaing, Brendish, Nathan J., Poole, Stephen, Tanner, Alex R., Borca, Florina, Smith, Trevor, Stammers, Matthew, Clark, Tristan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802147/ https://www.ncbi.nlm.nih.gov/pubmed/35108599 http://dx.doi.org/10.1016/j.jinf.2022.01.034

Ejemplares similares

SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death
por: Tanner, Alex R, et al.
Publicado: (2021)

Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus
por: Poole, Stephen, et al.
Publicado: (2020)

Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance
por: Tanner, Alex R, et al.
Publicado: (2021)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department – ADDENDUM
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection
por: Brendish, Nathan J, et al.
Publicado: (2020)

SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study
por: Poole, Stephen, et al.
Publicado: (2020)

Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol
por: Beard, Kate, et al.
Publicado: (2019)

1717. The Impact of Routine Molecular Point-of-care Testing for Gastrointestinal Pathogens in Adults Hospitalized With Suspected Gastroenteritis: Results of a Pragmatic Randomized Controlled Trial (GastroPOC)
por: Malachira, Ahalya, et al.
Publicado: (2018)

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study
por: Brendish, Nathan J, et al.
Publicado: (2020)

Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)
por: Brendish, Nathan J., et al.
Publicado: (2017)

654. Evaluation of the Febridx Host Response Point-of-Care Test to Differentiate Viral From Bacterial Etiology in Adults Hospitalized with Acute Respiratory Illness During Influenza Season
por: Beard, Kate, et al.
Publicado: (2019)

Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study
por: Brendish, Nathan J., et al.
Publicado: (2022)

Point-of-care testing for respiratory viruses in adults: The current landscape and future potential
por: Brendish, Nathan J., et al.
Publicado: (2015)

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial
por: Clark, Tristan W, et al.
Publicado: (2021)

Influenza vaccination: protecting the most vulnerable
por: Tanner, Alex R., et al.
Publicado: (2021)

2796. The Impact of Syndromic Molecular Point-of-Care Testing for Respiratory Viruses on Antibiotic Use in Adults Presenting to Hospital with Exacerbation of Airways Disease: Further Analysis From a Randomized Controlled Trial
por: Clark, Tristan William, et al.
Publicado: (2019)

Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease
por: Brendish, Nathan J., et al.
Publicado: (2019)

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19
por: Clark, Tristan W., et al.
Publicado: (2020)

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial
por: Brendish, Nathan J, et al.
Publicado: (2017)

120. Impact of a Molecular Point-of-care ‘test and Treat’ Strategy for Influenza in Hospitalised adults: A Multi-centre, Randomised Controlled Trial (FluPOC)
por: Clark, Tristan William, et al.
Publicado: (2020)

415. Clinical Impact of Molecular Point-of-Care Testing for COVID-19 in Adults Presenting to Hospital: A Prospective, Interventional, Non-Randomised, Controlled Study
por: Brendish, Nathan J, et al.
Publicado: (2020)

A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort
por: Ardern-Jones, Michael R., et al.
Publicado: (2023)

Re: 'Syndromic panels or “panel syndrome”? A perspective through the lens of respiratory-tract infections' by Zanella et al
por: Brendish, N.J., et al.
Publicado: (2020)

A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries
por: Humbert, Maria Victoria, et al.
Publicado: (2021)

Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation study
por: Stammers, Matthew, et al.
Publicado: (2022)

Optimisation of COVID‐19 diagnostic pathways in acute hospital admissions to prevent nosocomial transmission
por: Livingstone, Robert, et al.
Publicado: (2022)

Point-of-Care Testing—The Key in the Battle against SARS-CoV-2 Pandemic
por: Iliescu, Florina Silvia, et al.
Publicado: (2021)

SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
por: Hoffmann, Markus, et al.
Publicado: (2021)

High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning
por: McDonnell, Martin, et al.
Publicado: (2020)

SARS-CoV-2 in Nursing Homes: Analysis of Routine Surveillance Data in Four European Countries
por: Delory, Tristan, et al.
Publicado: (2023)

Can routine laboratory tests discriminate SARS‐CoV‐2‐infected pneumonia from other causes of community‐acquired pneumonia?
por: Pan, Yunbao, et al.
Publicado: (2020)

Inflammatory phenotyping predicts clinical outcome in COVID-19
por: Burke, H., et al.
Publicado: (2020)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2
por: Rooney, C.M., et al.
Publicado: (2021)

Routine SARS‐CoV‐2 vaccination for all children
por: De Paris, Kristina, et al.
Publicado: (2022)

SARS-CoV-2 diagnostics: Towards a more comprehensive approach to routine patient testing
por: Carter, Clive, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
por: Wang, Ruoke, et al.
Publicado: (2022)

The case for routine screening for SARS-CoV-2 before surgery
por: Tenenbein, Paul, et al.
Publicado: (2020)

SARS‐CoV‐2 RNA screening in routine pathology specimens
por: von Stillfried, Saskia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tpt81ccd38nepu5bqf1kipi0hf